
GC19418
Edicotinib
Also known as 5-cyano-N-[2-(4,4-dimethylcyclohexen-1-yl)-6-(2,2,6,6-tetramethyloxan-4-yl)-3-pyridinyl]-1H-imidazole-2-carboxamide
Edicotinib is a selective and orally available colony-stimulating factor-1 (CSF-1) receptor inhibitor, and has entered phase IIA clinical trial to study rheumatoid arthritis (RA) despite disease
ChemicalCAS1142363-52-7FormulaC27H35N5O2
- CAS number
- 1142363-52-7
- Molecular weight
- —
- Formula
- C27H35N5O2
- Solubility
- DMF: 30 mg/ml,DMSO: 30 mg/ml,DMSO:PBS (pH 7·2) (1:3): 0·25 mg/ml,Ethanol: 20 mg/ml
- InChIKey
- BNVPFDRNGHMRJS-UHFFFAOYSA-N
- Catalogue number
- GC19418
- Brand
- GLPBIO
Computed properties PubChem CID 25230468 · XLogP 4.3 · TPSA 104 Ų · H-bond donors 2
- XLogP
- 4.3
- TPSA
- 104 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 34
SMILES CC1(CCC(=CC1)C2=C(C=CC(=N2)C3CC(OC(C3)(C)C)(C)C)NC(=O)C4=NC=C(N4)C#N)C
Computed descriptors from PubChem (CID 25230468), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il